p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines
Authors:
Open Access
- 1 July 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 66 (1) , 94-102
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Combination Anti-Gene Therapy Targeting c-myc and p53 in Ovarian Cancer Cell LinesGynecologic Oncology, 1995
- Growth Characteristics of Nonmalignant Cells in the ATP Cell Viability AssayOncology, 1994
- A Unique c-myc-Targeted Triplex-Forming Oligonucleotide Inhibits the Growth of Ovarian and Cervical Carcinomas in VitroGynecologic Oncology, 1993
- Taxol Sensitizes Human Ovarian Cancer Cells to RadiationGynecologic Oncology, 1993
- Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroGynecologic Oncology, 1992
- Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological PhenotypesJapanese Journal of Cancer Research, 1992
- p53 function and dysfunctionCell, 1992
- An immunochemical analysis of the human nuclear phosphoprotein p53Journal of Immunological Methods, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988